{
  "disease_name": "Lesch-Nyhan syndrome",
  "orpha_code": "510",
  "trials": [
    {
      "nctId": "NCT04641741",
      "briefTitle": "Effect of Mepolizumab on Severe Eosinophilic Asthma",
      "officialTitle": "Effect of Mepolizumab on the Phenotype/Proteome/Transcriptome of Eosinophils in Severe Eosinophilic Asthma",
      "overallStatus": "RECRUITING",
      "studyType": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Asthma",
        "Eosinophilic Asthma"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Mepolizumab 100 MG"
        }
      ],
      "enrollment": 30,
      "locations": [
        {
          "facility": "Complejo Hospitalario Universitario de Ferrol",
          "city": "Ferrol",
          "country": "Spain"
        },
        {
          "facility": "Hospital Clínico Universitario de Santiago de Compostela",
          "city": "Santiago De Compostela",
          "country": "Spain"
        },
        {
          "facility": "Hospital Povisa - Grupo Ribera Salud",
          "city": "Vigo",
          "country": "Spain"
        },
        {
          "facility": "Complexo Hospitalario Universitario A Coruña",
          "city": "A Coruña",
          "country": "Spain"
        },
        {
          "facility": "Complexo Hospitalario Universitario de Ourense",
          "city": "Ourense",
          "country": "Spain"
        }
      ],
      "lastUpdateDate": "2023-09-25"
    }
  ],
  "processing_timestamp": "2025-07-07T03:15:02.726652",
  "run_number": 1,
  "total_trials_found": 1
}